355 related articles for article (PubMed ID: 28709694)
21. Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.
Boonk SE; Çetinözman F; Vermeer MH; Jansen PM; Willemze R
J Cutan Pathol; 2015 Sep; 42(9):604-9. PubMed ID: 25777533
[TBL] [Abstract][Full Text] [Related]
22. [The Sézary syndrome].
Ferreira F; Correia TM; Callabro L; Andrade J
Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
[TBL] [Abstract][Full Text] [Related]
23. Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System.
Roccuzzo G; Giordano S; Avallone G; Rubatto M; Canonico S; Funaro A; Ortolan E; Senetta R; Fava P; Fierro MT; Ribero S; Quaglino P
Cells; 2022 Jan; 11(3):. PubMed ID: 35159143
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma.
Moriarty B; Whittaker S
Expert Rev Hematol; 2015 Apr; 8(2):159-71. PubMed ID: 25495961
[TBL] [Abstract][Full Text] [Related]
25. A modified staging classification for cutaneous T-cell lymphoma.
Kashani-Sabet M; McMillan A; Zackheim HS
J Am Acad Dermatol; 2001 Nov; 45(5):700-6. PubMed ID: 11606919
[TBL] [Abstract][Full Text] [Related]
26. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic tools in Sezary syndrome.
Möbs M; Knott M; Fritzen B; Pullmann S; Sterry W; Assaf C
G Ital Dermatol Venereol; 2010 Jun; 145(3):385-91. PubMed ID: 20461046
[TBL] [Abstract][Full Text] [Related]
28. Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome.
Fierro MT; Comessatti A; Quaglino P; Ortoncelli M; Osella Abate S; Ponti R; Novelli M; Bernengo MG
Dermatology; 2006; 213(4):284-92. PubMed ID: 17135733
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
[TBL] [Abstract][Full Text] [Related]
31. Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival.
Sigurdsson V; Toonstra J; Hezemans-Boer M; van Vloten WA
J Am Acad Dermatol; 1996 Jul; 35(1):53-7. PubMed ID: 8682964
[TBL] [Abstract][Full Text] [Related]
32. Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report.
Gahongayire F
Int J Dermatol; 2007 Oct; 46 Suppl 1():32-5. PubMed ID: 17919204
[TBL] [Abstract][Full Text] [Related]
33. Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center.
Miyashiro D; Sanches JA
Sci Rep; 2020 Jun; 10(1):9774. PubMed ID: 32555205
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic criteria in Sézary's syndrome: a multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma.
Willemze R; van Vloten WA; Hermans J; Damsteeg MJ; Meijer CJ
J Invest Dermatol; 1983 Nov; 81(5):392-7. PubMed ID: 6226746
[TBL] [Abstract][Full Text] [Related]
35. Case records of the Massachusetts General Hospital. Case 24-2013. A 53-year-old woman with erythroderma, pruritus, and lymphadenopathy.
Carter JB; Barnes JA; Niell BL; Nardi V
N Engl J Med; 2013 Aug; 369(6):559-69. PubMed ID: 23924007
[No Abstract] [Full Text] [Related]
36. Sézary syndrome: diagnostic criteria and therapeutic options.
Russell-Jones R; Whittaker S
Semin Cutan Med Surg; 2000 Jun; 19(2):100-8. PubMed ID: 10892711
[TBL] [Abstract][Full Text] [Related]
37. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
Smith BD; Wilson LD
Oncology (Williston Park); 2003 Sep; 17(9):1281-8. PubMed ID: 14569854
[TBL] [Abstract][Full Text] [Related]
38. Sézary syndrome: a study of 176 patients at Mayo Clinic.
Kubica AW; Davis MD; Weaver AL; Killian JM; Pittelkow MR
J Am Acad Dermatol; 2012 Dec; 67(6):1189-99. PubMed ID: 22640839
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of cutaneous T-cell lymphoma.
Abel EA
Dermatol Clin; 1985 Oct; 3(4):647-64. PubMed ID: 2878755
[TBL] [Abstract][Full Text] [Related]
40. Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single-centre experience.
Atzmony L; Amitay-Laish I; Gurion R; Shahal-Zimra Y; Hodak E
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2382-9. PubMed ID: 26299651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
